Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis

2017391 citationsJournal Articlegold Open Access

Authors

Chengping Wen · Zhejiang Chinese Medical University

Zhijun Zheng

Tiejuan Shao · Zhejiang Chinese Medical University

Lin Liu · State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Zhijun Xie · Zhejiang Chinese Medical University

Emmanuelle Le Chatelier · Département Génétique Animale

Zhixing He · Zhejiang Chinese Medical University

Abstract

Alterations of the gut microbiome are associated with development of ankylosing spondylitis. Our data suggest biomarkers identified in this study might participate in the pathogenesis or development process of ankylosing spondylitis, providing new leads for the development of new diagnostic tools and potential treatments.

Topics & Keywords

Spondyloarthritis Studies and Treatments Gut microbiota and health Inflammatory Bowel Disease

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Genome biology

Volume 18, Issue 1, pp. 142-142

DOI: 10.1186/s13059-017-1271-6

Field-Weighted Citation Impact: 23.89